TP53, EGFR and PIK3CA gene variations observed as prominent biomarkers in breast and lung cancer by plasma cell-free DNA genomic testing.
J Biotechnol
; 300: 87-93, 2019 Jul 20.
Article
in En
| MEDLINE
| ID: mdl-31100334
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Tumor Suppressor Protein p53
/
Class I Phosphatidylinositol 3-Kinases
/
Circulating Tumor DNA
/
Lung Neoplasms
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Biotechnol
Journal subject:
BIOTECNOLOGIA
Year:
2019
Type:
Article